Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F‐MDMB‐PICA
Drug Testing and Analysis · 2024
DOI: 10.1002/dta.3680 ↗At a glance
Journal article in Drug Testing and Analysis, 2024. Written by Rui-Jia Chen and 17 co-authors. Institution: Shanghai Key Laboratory of Crime Scene Evidence, Shanghai Research Institute of Criminal Science and Technology, Shanghai, China. Major MEDLINE topics: Cannabinoids, Tandem Mass Spectrometry. Cited 1 times so far (Crossref); 34 references. Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China, Science and Technology Development Fund of Shanghai Municipal Public Security Bureau.
Abstract (original language)
5F‐MDMB‐PICA, an indole‐type synthetic cannabinoid (SC), was classified illicit globally in 2020. Although the extensive metabolism of 5F‐MDMB‐PICA in the human body warrants the development of robust analytical methods for metabolite detection and quantification, a current lack of reference standards for characteristic metabolites hinders such method creation. This work described the synthesis of 18 reference standards for 5F‐MDMB‐PICA and its possible Phase I metabolites, including three hydroxylated positional isomers R14 to R16 . All the compounds were systematic characterized via nuclear magnetic resonance, Fourier transform infrared spectroscopy, and high‐resolution mass spectrometry. Furthermore, two methods were developed for the simultaneous detection of all standards using liquid chromatography–tandem mass spectrometry and ultra‐performance liquid chromatography–quadrupole time‐of‐flight mass spectrometry. By comparison with authentic samples, R17 was identified as a suitable urine biomarker for 5F‐MDMB‐PICA uptake.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Shanghai Key Laboratory of Crime Scene Evidence, Shanghai Research Institute of Criminal Science and Technology, Shanghai, China.
- Shanghai Yuansi Standard Science and Technology Co., Ltd, Shanghai, China.
- College of Materials Science and Engineering, National Engineering Research Center for Magnesium Alloys, Chongqing University, Chongqing, China.
ORCID profiles: Rui-Jia Chen
Funding
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Science and Technology Development Fund of Shanghai Municipal Public Security Bureau
Cite
APA
Chen, R. J., Zhang, Z. H., Yang, S., Yu, S. C., Wang, J. C., Liao, P. Y., Qiu, T. T., Xiao, L., Xue, S., Chen, H., Shao, W. B., Hu, J. W., Lan, Y., Chen, X. L., Xu, Y., Zhou, T. M., Zhao, X. J., & Liu, W. B. (2024). Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F‐MDMB‐PICA. Drug Testing and Analysis. https://doi.org/10.1002/dta.3680
Vancouver
Chen RJ, Zhang ZH, Yang S, Yu SC, Wang JC, Liao PY, et al. Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F‐MDMB‐PICA. Drug Testing and Analysis. 2024. doi:10.1002/dta.3680
BibTeX
@article{Chen2024,
author = {Chen, Rui-Jia and Zhang, Zi-Hua and Yang, Shenglan and Yu, Shu-Chen and Wang, Jun-Chang and Liao, Ping-Yong and Qiu, Ting-Ting and Xiao, Lu and Xue, Shang and Chen, Hong and Shao, Wen-Bin and Hu, Jian-Wen and Lan, Yun and Chen, Xi-Long and Xu, Yue and Zhou, Tian-Meng and Zhao, Xue-Jun and Liu, Wen-Bin},
title = {Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F‐MDMB‐PICA},
journal = {Drug Testing and Analysis},
year = {2024},
doi = {10.1002/dta.3680}
}
EUVIMED